Transoral surgery may be less cost effective than radiotherapy: In response to: Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-medicare analysis

MeSH terms

• Aged
• Cost-Benefit Analysis
• Humans
• Medicare
• Oropharyngeal Neoplasms* / radiotherapy
• Oropharyngeal Neoplasms* / surgery
• Radiotherapy / economics
• SEER Program
• Squamous Cell Carcinoma of Head and Neck* / radiotherapy
• Squamous Cell Carcinoma of Head and Neck* / surgery
• Surgical Procedures, Operative / economics
• Treatment Outcome
• United States